Impact of prior bevacizumab therapy on the incidence of ramucirumab-induced proteinuria in colorectal cancer: a multi-institutional cohort study

ConclusionSequential FOLFIRI plus RAM after BEV failure, especially within 55  days, may exacerbate proteinuria. Its escalated anti-VEGF toxicity may negatively impact the overall survival.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research